Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Onyda XR (clonidine hydrochloride) Non-Stimulant Liquid Treatment for ADHD

May 29, 2024 – Business Wire – Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity...

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma

(BUSINESS WIRE) May 30, 2024 -- Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted approval for...

FDA Approves Bkemv (eculizumab-aeeb), an Interchangeable Biosimilar to Soliris

Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat...

Mindfulness Meditation: What Are Its Potential Health Benefits?

Can mindfulness meditation be good medicine for both mental and physical ills?Yes, says one expert who explains the practice and what conditions it might...

Preeclampsia Linked to Increased Risk for Young-Onset Dementia

Individuals with preeclampsia have an increased risk for young-onset dementia, according to a research letter published online May 30 in JAMA Network Open.Valérie...

Binge Eating in Adults Improves Over Time, but Relapse Common

Binge-eating disorder (BED) does improve over time; however, remission often takes many years, according to a study published online May 28 in Psychological...

Racial Disparity Seen in Naloxone Administration

In Pennsylvania, from 2019 to 2021, Black people who died from overdose deaths had lower odds of naloxone administration compared with White and Hispanic...

Active Surveillance Effective Strategy for Favorable-Risk Prostate Cancer

Active surveillance is an effective management strategy for men with favorable-risk prostate cancer, with an estimated rate of metastasis of 1.4 percent...

Mediterranean Diet Cuts Women's Risk of Early Death by 23%

Experts have long extolled the benefits of the Mediterranean diet and a new study adds to that evidence, finding it cuts the odds for an early death in...

Almost 1 in 3 Americans Know Someone Who's Died From a Drug Overdose

As the opioid addiction crisis continues to lay waste to American life, a new survey finds that nearly a third of U.S. adults now know someone who's died...

1 in 8 Older Americans Are Stricken With Traumatic Head Injury

About one in eight U.S. seniors will be treated for a traumatic brain injury, typically during a fall, a new study finds. Medicare data shows that about...

Avirmax Biopharma Inc. Receives IND Approval for Phase I/IIa Trial to Treat Wet AMD including PCV

HAYWARD, Calif., May 30, 2024. Avirmax Biopharma, Inc., a leading innovator in genetic medicines, is pleased to announce that it has received Investigational...

Novartis Phase III Data Confirm Sustained Efficacy and Long-Term Safety of Oral Remibrutinib in Chronic Spontaneous Urticaria

Basel, May 31, 2024 – Novartis today announced new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective Bruton’s...

U.S. FDA Acknowledges Astellas' Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has acknowledged...

Could Tattoos Be Linked to Blood Cancer Risk?

Research suggests that tattoo ink spurs inflammatory changes that might contribute to the development of lymphoma. The findings are early, however, and...

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to Potential Presence of Particulate Matter

SCHAUMBURG, IL – May 28, 2024 – Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection,...

Read more news...

Recently Added

Recently added consumer and prescribing information: Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Onyda XR Onyda XR is a once-daily extended-release oral suspension of clonidine hydrochloride for the treatment of attention-deficit/hyperactivity...
  • Bkemv Bkemv (eculizumab-aeeb) is a complement inhibitor interchangeable biosimilar to Soliris for the treatment of paroxysmal nocturnal...
  • Yesafili Yesafili (aflibercept-jbvf) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development